Related Experiment Videos
Epithelioid sarcoma: Still an only surgically curable disease
Sebastiaan A H J de Visscher1, Robbert J van Ginkel, Theo Wobbes
1Department of Surgical Oncology, University Medical Center Groningen and University of Groningen, Groningen, the Netherlands.
Cancer
|June 29, 2006
Summary
Epithelioid sarcoma has a poor prognosis, with high recurrence and metastasis rates. Tumor size and local recurrence significantly impact survival, necessitating radical surgical excision and potentially isolated limb perfusion for large tumors.
Area of Science:
- Oncology
- Surgical Pathology
- Sarcoma Research
Background:
- Epithelioid sarcoma is a rare soft tissue malignancy.
- Characterized by a high propensity for locoregional recurrence and distant metastases.
- Understanding clinical behavior and prognostic factors is crucial for patient survival.
Purpose of the Study:
- To investigate the clinical behavior of epithelioid sarcoma.
- To identify prognostic factors influencing patient survival.
- To evaluate treatment outcomes for epithelioid sarcoma.
Main Methods:
- Retrospective review of 23 epithelioid sarcoma patients treated between 1979-2003.
- Analysis included patient demographics, metastasis at diagnosis, and treatment modalities.
- Treatments comprised palliative care, surgical excision, and isolated limb perfusion.
Main Results:
- 5-year and 10-year disease-free survival rates were 34% and 17% for all patients, respectively.
- Curative treatment yielded 56% disease-free survival, but 50% experienced local recurrence.
- Tumor size >5 cm and local recurrence were significant negative predictors of survival.
Conclusions:
- Epithelioid sarcoma carries a poor prognosis due to frequent presentation with extensive disease and metastases.
- Radical surgical excision and therapeutic lymph node dissection are recommended treatments.
- Isolated limb perfusion may benefit patients with large tumors.